Login
From:
Alzheimer's Disease and Dementia
(Uncensored)
subscribe
FDA Approves Kisunla (Donanemab) | Alzheimer's Association
https://www.alz.org/news/2024/fda-approve-kisunla-donanemab-alzheimers-treatment
links
backlinks
The Alzheimer’s Association celebrates today’s FDA approval of Kisunla™ (donanemab) for the treatment of people living with early symptomatic Alzheimer’s.
Roast topics
Find topics
Find it!
